Elma Aflaki, Wendy Westbroek, Ellen Sidransky  Neuron 

Slides:



Advertisements
Similar presentations
Autophagy Part 1 Dr Aliwaini.
Advertisements

Volume 8, Issue 3, Pages (March 2017)
Regulation of inflammasomes by autophagy
New Animal Models for Parkinson's Disease
Alicia M. Pickrell, Richard J. Youle  Neuron 
Acetylation Unleashes Protein Demons of Dementia
The Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis
Sphingolipid Signaling in Metabolic Disorders
Volume 140, Issue 7, Pages (June 2011)
Defective autophagy leads to cancer
Volume 139, Issue 5, Pages (November 2010)
Autophagy Meets Phagocytosis
Harold A. Franch, MD  Journal of Renal Nutrition 
Figure 1 ER stress and associated lines of defence
Kv1.1 Takes a deTOR from the Axon to the Dendrite
Methed-Up FOXOs Can't In-Akt-ivate
Volume 15, Issue 8, Pages R282-R283 (April 2005)
Autophagy and Aging Cell
ALS Genes in the Genomic Era and their Implications for FTD
Is REDD1 a Metabolic Éminence Grise?
Volume 72, Issue 1, Pages 9-21 (October 2011)
Great Expectations for PIP: Phosphoinositides as Regulators of Signaling During Development and Disease  Lara C. Skwarek, Gabrielle L. Boulianne  Developmental.
Plant Hormones and Signaling: Common Themes and New Developments
Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers
α-Synuclein and Tau: Mitochondrial Kill Switches
Autophagy, Apoptosis, and the Influenza Virus M2 Protein
Independent Control of Aging and Axon Regeneration
Capturing VCP: Another Molecular Piece in the ALS Jigsaw Puzzle
Volume 80, Issue 2, Pages (October 2013)
Autophagy in kidney disease and aging: lessons from rodent models
Volume 84, Issue 1, Pages (July 2013)
Volume 28, Issue 5, Pages (November 2015)
Cystic Fibrosis as a Disease of Misprocessing of the Cystic Fibrosis Transmembrane Conductance Regulator Glycoprotein  John R. Riordan  The American Journal.
Shedding Light on Mammalian Microautophagy
Volume 8, Issue 3, Pages (March 2017)
Autophagy in the Pathogenesis of Disease
Neuronal Aggregates: Formation, Clearance, and Spreading
Lucifer's Labyrinth—Ten Years of Path Finding in Cell Death
Pharmacological Chaperone Therapy: Preclinical Development, Clinical Translation, and Prospects for the Treatment of Lysosomal Storage Disorders  Giancarlo.
Steroid hormones: Interactions with membrane-bound receptors
Amino acid-dependent regulation of autophagy by mTORC1
Jacqueline M. Kimmey, Christina L. Stallings 
Anna S. Gukovskaya, Ilya Gukovsky, Hana Algül, Aida Habtezion 
Volume 74, Issue 5, Pages (September 2008)
Rab GTPases and Membrane Trafficking in Neurodegeneration
Volume 93, Issue 5, Pages (March 2017)
Volume 123, Issue 6, Pages (December 2002)
Tumor Metabolism: MAGE-A Proteins Help TRIM Turn Over AMPK
The Ubiquitin Proteasome System in Neurodegenerative Diseases
The Process of Autophagy
DUB-le Trouble for Cell Survival
A Feedforward Loop Links Gaucher and Parkinson's Diseases?
Genetic Animal Models of Parkinson's Disease
Diego Varela, Gerald W. Zamponi  Neuron 
Autophagy in liver diseases: Time for translation?
Ethylene Prunes Translation
Long Noncoding RNAs and Hepatocellular Carcinoma
Autophagy Captures the Nobel Prize
Michael J. Clague, Han Liu, Sylvie Urbé  Developmental Cell 
Genetics of hypercalciuric stone forming diseases
The Stressed CNS: When Glucocorticoids Aggravate Inflammation
Streptococcus pyogenes Escapes from Autophagy
Understanding Dopaminergic Cell Death Pathways in Parkinson Disease
Autophagy in the Cellular Energetic Balance
Autophagy and the Integrated Stress Response
Autophagy: Renovation of Cells and Tissues
Yang Cang-Jin , Zhang Chi , Lu Yang-Ning , Jin Jia-Qi , Wang Xue-Lu  
UPR and cross-talk between apoptosis and metabolism.
Novel pharmacological strategies to treat cystic fibrosis
Dendritic Tau in Alzheimer’s Disease
Presentation transcript:

The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease  Elma Aflaki, Wendy Westbroek, Ellen Sidransky  Neuron  Volume 93, Issue 4, Pages 737-746 (February 2017) DOI: 10.1016/j.neuron.2017.01.018 Copyright © 2017 Terms and Conditions

Figure 1 The Inverse Relationship between α-synuclein and Glucocerebrosidase Multiple factors can impact the inverse relationship, including those leading to too much α-syn or too little GCase. Neuron 2017 93, 737-746DOI: (10.1016/j.neuron.2017.01.018) Copyright © 2017 Terms and Conditions

Figure 2 Pathways that Might Contribute to the Association between GD and PD Wild-type GCase is produced in the ER, glycosylated in the Golgi, and is translocated to the lysosome, where it degrades its substrate, GlcCer. (1) Mutant GCase may undergo proteosomal breakdown and is not translocated to lysosomes. (1a) GlcCer accumulates in the lysosome, which subsequently may lead to α-syn aggregation; however, not all individuals carrying a mutation develop PD. (2) In PD, the oligomeric form of α-syn may suppress ER-Golgi trafficking of GCase, which can result in reduced GCase activity. (3) α-syn is a substrate for a selective form of autophagy (chaperone-mediated autophagy, CMA) and interacts with the cytosolic chaperone (HSC70), enabling its translocation to the lysosome with the help of Lamp2a, a receptor for CMA on the lysosomal membrane. It is not known whether GCase is a substrate for CMA or whether CMA is affected in patients with PD and GD. (4) Macroautophagy could be affected. Accumulation of ubiquitinated proteins and p62 in the autophagosome inhibits fusion between the autophagosome and the lysosome, which augments the accumulation of autophagosomes in the cells. These eventually inhibit macroautophagy and impair lysosomal function. (5) Transcription factor EB (TFEB), a key regulator of lysosome biogenesis may play a role. Under normal conditions, mTOR interacts with TFEB on the surface of the lysosome, which leads to TFEB phosphorylation and cytosolic sequestration of this transcription factor. When autophagy is impaired or mTOR is inhibited, TFEB is no longer phosphorylated, which results in the dissociation of TFEB from the lysosome and its translocation to the nucleus. α-syn accumulation or lysosomal dysfunction could inhibit translocation of TFEB to the nucleus, leading to the accumulation of phosphorylated TFEB on the lysosome. Neuron 2017 93, 737-746DOI: (10.1016/j.neuron.2017.01.018) Copyright © 2017 Terms and Conditions